MX2012005380A - Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia. - Google Patents

Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia.

Info

Publication number
MX2012005380A
MX2012005380A MX2012005380A MX2012005380A MX2012005380A MX 2012005380 A MX2012005380 A MX 2012005380A MX 2012005380 A MX2012005380 A MX 2012005380A MX 2012005380 A MX2012005380 A MX 2012005380A MX 2012005380 A MX2012005380 A MX 2012005380A
Authority
MX
Mexico
Prior art keywords
high efficiency
protein
biomarkers
secretory
protein expression
Prior art date
Application number
MX2012005380A
Other languages
English (en)
Inventor
Ivan R Correia
Patrick Hossler
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2012005380A publication Critical patent/MX2012005380A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere al campo de la producción de proteínas y en particular se refiere a composiciones y procesos para mejorar los niveles de producción de proteínas recombinantes expresadas en las células huésped.
MX2012005380A 2009-11-09 2010-11-09 Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia. MX2012005380A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25952709P 2009-11-09 2009-11-09
US12/941,347 US8524458B2 (en) 2009-11-09 2010-11-08 Secretory protein biomarkers for high efficiency protein expression
PCT/US2010/055953 WO2011057239A2 (en) 2009-11-09 2010-11-09 Secretory protein biomarkers for high efficiency protein expression

Publications (1)

Publication Number Publication Date
MX2012005380A true MX2012005380A (es) 2012-05-29

Family

ID=43431809

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005380A MX2012005380A (es) 2009-11-09 2010-11-09 Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia.

Country Status (14)

Country Link
US (2) US8524458B2 (es)
EP (1) EP2499254A2 (es)
JP (1) JP2013510324A (es)
KR (1) KR20120115494A (es)
CN (1) CN102666873A (es)
AU (1) AU2010314922A1 (es)
BR (1) BR112012010976A2 (es)
CA (1) CA2778254A1 (es)
IL (1) IL219518A0 (es)
IN (1) IN2012DN03358A (es)
MX (1) MX2012005380A (es)
RU (1) RU2012124114A (es)
WO (1) WO2011057239A2 (es)
ZA (1) ZA201202966B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6507542B2 (ja) * 2014-09-22 2019-05-08 東洋紡株式会社 バイオマーカーを用いた組換えタンパク質生産量の予測方法
EP3255054A1 (en) 2016-06-06 2017-12-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the purification of biological macromolecular complexes
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
CN109470756B (zh) * 2018-10-11 2020-08-25 昆明理工大学 测定14-3-3蛋白与质膜H+-ATPase蛋白互作的电化学方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
US5302517A (en) * 1987-06-16 1994-04-12 The Board Of Regents Of The University Of Nebraska Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20050272055A1 (en) * 2000-02-01 2005-12-08 Rina Das Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
AU2007314524A1 (en) * 2006-04-21 2008-05-08 Dublin City University Differential expression profiling analysis of cell culture phenotypes and the uses thereof
US8242057B2 (en) * 2006-06-26 2012-08-14 Cleveland Biolabs, Inc. Methods for identifying modulators of apoptosis
CA2726563A1 (en) * 2008-06-04 2009-12-10 Proteosys Ag Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances

Also Published As

Publication number Publication date
US8524458B2 (en) 2013-09-03
WO2011057239A2 (en) 2011-05-12
EP2499254A2 (en) 2012-09-19
RU2012124114A (ru) 2013-12-20
IL219518A0 (en) 2012-06-28
WO2011057239A3 (en) 2011-06-30
IN2012DN03358A (es) 2015-10-23
AU2010314922A1 (en) 2012-05-31
CN102666873A (zh) 2012-09-12
KR20120115494A (ko) 2012-10-18
ZA201202966B (en) 2012-12-27
US20140004531A1 (en) 2014-01-02
BR112012010976A2 (pt) 2016-08-16
US20110236906A1 (en) 2011-09-29
JP2013510324A (ja) 2013-03-21
CA2778254A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
IN2014CN02100A (es)
IN2012DN06277A (es)
MY186219A (en) Production of proteins in glutamine-free cell culture media
EP2470670A4 (en) COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
IN2012DN03825A (es)
EP2536821A4 (en) IMPROVING THE ACTIVITY OF PROTEINS REQUIRING AGGREGATE FE-S
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
EA201270151A1 (ru) Способы и композиции для рекомбинантного биосинтеза h-алканов
EA201190326A1 (ru) Полипептиды гормона роста и способы их получения и применения
IN2014CN04586A (es)
WO2014035475A8 (en) Methods to control protein heterogeneity
EP3805348A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
MX346700B (es) Metodo para mejorar el rendimiento de un polipeptido.
MX2014001383A (es) Colageno 7 y metodos relacionados.
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX346518B (es) Metodos de desarrollo de variantes de terpeno sintasa.
MX2014004598A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EA201290565A1 (ru) Получение белка гемагглютинин-нейраминидазы в микроводорослях
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
MX2014003403A (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
MX2012005380A (es) Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia.
EA201200186A1 (ru) Вектор, содержащий промотор маннозы, и промотор маннозы
MX2013009403A (es) Agrupamiento genico para la biosintesis de cicloclavina.
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
GEP201606542B (en) Recombinant expression of soluble interferon

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ABBVIE INC.

FA Abandonment or withdrawal